Bio-Techne Corporation

Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets globally. Its operations are divided into two segments: Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment produces biological reagents such as cytokines, growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies, as well as proteomic analytical tools for automated western blot and multiplexed ELISA workflows. The Diagnostics and Genomics segment offers diagnostic products like controls, calibrators, and assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic analysis, and genetic and oncology kits for research and clinical applications. It also sells instruments and process control products for hematology, blood chemistry, and coagulation.

Bio-Techne Corporation is listed on the NasdaqGS exchange under the ticker symbol TECH. Its shares are traded in United States Dollars (USD). The company is headquartered in Minneapolis, Minnesota, and was incorporated in 1976. It was formerly known as Techne Corporation before rebranding to Bio-Techne.

Bio-Techne Corporation operates in the Healthcare sector and is classified under the Biotechnology industry. The company focuses on developing and manufacturing life science reagents, instruments, and services for research, diagnostics, and bioprocessing markets. Its products support a wide range of applications, including cell and gene therapy, proteomics, molecular diagnostics, and spatial biology.

Bio-Techne Corporation is headquartered in Minneapolis, Minnesota, United States. It serves global markets, including the research, diagnostics, and bioprocessing sectors. The company's products are used in various applications such as life science research, clinical diagnostics, and cell and gene therapy. Its geographic reach is worldwide, with a presence in multiple regions through its two segments: Protein Sciences and Diagnostics and Spatial Biology.

Bio-Techne generates revenue through two main segments: Protein Sciences and Diagnostics and Spatial Biology. The Protein Sciences segment sells biological reagents (cytokines, growth factors, antibodies, small molecules, tissue culture sera, cell selection technologies) and proteomic analytical tools for protein analysis. The Diagnostics and Genomics segment provides diagnostic products such as controls, calibrators, assays for regulated diagnostics, exosome-based molecular diagnostic assays, tissue-based in-situ hybridization assays for spatial genomics, and genetic/oncology kits. It also offers instruments and process control products for hematology, blood chemistry, and coagulation. Revenue comes from both research and clinical applications globally.